CCVAX: Profile for CALVERT SMALL CAP VALUE FUND CL

McKissack is a Founding Principal, and serves as the chief executive officer and chief investment officer of Channing Capital Management, LLC. He has over 25 years of investment experience. He was formerly vice-chairman and co-chief investment officer of Ariel Capital Management, a Chicago-based investment management firm with over $10 billion in assets under management in 2003, specializing in equities.

INVESTMENT INFORMATION

Min Initial Investment:	$1,000
Min Initial Investment, IRA:	$1,000
Min Initial Investment, AIP:	NaN
Min Subsequent Investment:	$250
Min Subsequent Investment, IRA:	$250
Min Subsequent Investment, AIP:	N/A

CCVAX can be purchased from brokerages.

FUND SUMMARY

The investment seeks to provide long-term capital appreciation. The fund normally invests at least 80% of assets in the common stocks of small U.S. companies that have a market capitalization of $2 billion or less at the time of initial purchase. It invests with the philosophy that long-term rewards to investors comes from those organizations whose products, services, and methods enhance the human condition and what it views as the traditional American values of individual initiative, equality of opportunity, and cooperative effort. The fund may invest up to 20% of net assets in foreign securities.

FUND OPERATIONS

Last Dividend	YFT_NOT_APPLICABLE_ABBREVIATION
Last Cap Gain (8-Dec-05):	0.01
Annual Holdings Turnover	62.00%
Average for Category:	91.53%

FEES & EXPENSES

Expense	CCVAX	Category Avg
Total Expense Ratio:	%	1.41%
Max 12b1 Fee:	%	N/A
Max Front End Sales Load:	4.75%	5.36%
Max Deferred Sales Load:	%	2.34%
3 Yr Expense Projection*:	$ YFT_NOT_APPLICABLE_ABBREVIATION	$620
5 Yr Expense Projection*:	$ YFT_NOT_APPLICABLE_ABBREVIATION	$994
10 Yr Expense Projection*:	$ YFT_NOT_APPLICABLE_ABBREVIATION	$2,000

* Per $10,000 invested

Add to Portfolio

Set Alert

Email to a Friend

•

Top Performers by Style

•

Morningstar Editorials